Reason for request

Inclusion

No clinical benefit demonstrated when compared with intravenous patient-controlled analgesia, in the treatment of acute moderate to severe post-operative pain in adult patients

 

  • IONSYS has Marketing Authorisation in the treatment of acute moderate to severe post-operative pain in adult patients.
  • The administration device of IONSYS involves electrically assisted transdermal iontophoresis. No benefit has been demonstrated by comparison with intravenous, patient-controlled analgesia.

 


Clinical Benefit

Substantial

-


Clinical Added Value

no clinical added value

-


Therapeutic use

-

Contact Us

Évaluation des médicaments